Page 84 - Revol6
P. 84
Evaluación del uso de drogas en personas con trastorno mental grave
P «Medición clínica en psiquiatría y psicología» Masson; pp. 57. Skinner HA. The drug abuse screening test. Addict XXXill
245-54 1982;7(4):363-71
37. Dixon L., Haas, G., Weiden P., Sweeney J., Frances A.: Drug
abuse in schizophrenic patients: clinical correlates and reasons for 58. Maisto SA, Carey MP, Carey KB, Gordon CM, Gleason JR. Use
use. American Journal of Psychiatry 1991; 141:224-30. of the AUDIT and the DAST-10 to identify alcohol and drug use
38. Shaner A, Khalsa E, Roberts L: Unrecognized cocaine use among disorders among adults with a severe and persistent mental ill-
schizophrenic patients. American Journal of Psychiatry 150:758- ness. Psychological Assessment. 2000;12:186–192.
762, 1993[Medline]
39. Stone AM, Greenstein RA, Gamble G, McLellan AT: Cocaine use 59. Cocco KM; Carey KB. Psychometric properties of the Drug
by schizophrenic outpatients who receive depot neuroleptic Abuse Screening Test in psychiatric outpatients. Psychological
medication. Hosp Community Psychiatry 1993; 44:176–177. Assessment 10(4): 408-414, 1998.
40. Jackson CR, Covell NH, Frisman LK, Essock SM. Validity of
Self-Reported Drug Use Among People with Co-Occurring 60. Carey KB, Carey MP, Chandra PS. Psychometric evaluation of
Mental Health and Substance Use Disorders. Journal of Dual the alcohol use disorders identification test and short drug abuse
Diagnosis: Volume: 1 Issue: 1. 2005: 49 – 63 screening test with psychiatric patients in India. J Clin
41. Babor TF, de la Fuente JR, Saunders J. AUDIT, The Alcohol Use Psychiatry. 2003 Jul; 64(7):767-74.
Disorders dentification Test: guidelines for use in primary health
care (WHO Publ No PSA/92.4). Geneva, World Health 61. Bedregal LE, Sobell LC, Sobell MC and Simco E. Psychometric
Organization, 1992. characteristics of a Spanish version of the DAST-10 and the
42. Sobell, L. C., & Sobell, M. B. (1995). Alcohol consumption mea- RAGS» Addictive Behavior 31/2 (2006) 309–319.
sures. In J. P. Allen & M. Columbus (Eds.), Assessing alcohol
problems: A guide for clinicians and researchers (4 ed., pp. 55- 62. Babor TF, de la Fuente JR, Saunders J. AUDIT, The Alcohol Use
76). Washington D.C.: U.S. Govt Printing Office. Disorders dentification Test: guidelines for use in primary health
43. Weiss RD, Najavits LM, Greenfield SF, Soto JA, Shaw SR, and care (WHO Publ No PSA/92.4). Geneva, World Health
Wyner D. Validity of Substance Use Self-Reports in Dually Organization, 1992.
Diagnosed Outpatients. Am J Psychiatry 155:1, January 1998.
44. El-Guebaly N, Hodgins DC, Armstrong S, Addington J. 63. Saunders JB, Aasland OG, Babor TF, de la Fuente J, Grant M.
Methodological and clinical challenges in evaluating treatment Development of the Alcohol Use Disorders Identification Test
outcome of substance-related disorders and comorbidity. Can J (AUDIT): WHO collaborative project on early detection of per-
Psychiatry. 1999 Apr;44(3):264-70. sons with harmful alcohol consumption-II. Addiction 1993; 88:
45. Schiller MJ, Shumway M, Batki SL: Utility of routine drug scre- 791-804.
ening in a psychiatric emergency setting. Psychiatric Services
51:474-478, 2000. 64. Rubio G, Bermejo J, Caballero MC, Santo– Domingo J.
46. McPhillips MA, Nelly FJ, Barnes TR, Duke PJ, Gene-Cos N, Validación de la prueba para la identificación de trastornos por el
Clark K. Detecting comorbid substance misuse among people uso de alcohol (AUDIT) en atención primaria. Rev Clin Esp
with schizophrenia in the community: a study comparing the 1998; 198: 11-4.
results of questionnaires with analysis of hair and urine.
Schizophrenia Research. Vol 25, Issue 2 , 24 1997, Pp 141-148. 65. Rubio G y Rosenber Rosenberg SD (2002) Evaluación del uso de
47. CODI Co-occurring Mental Health and Substance Use Disorders drogas y de los trastornos por uso de sustancias en sujetos con
Initiative [Winnipeg Region] http://www. afm.mb.ca/codi.html otros trastor trastornos psiquiátricos. En Rubio G, López-Muñoz
48. Uriarte, JJ; Beramendi, V; Medrano, J. Presentación de la tra- F F, Alamo C, Santo-Domingo J (edit). Trastornos psiquiatricos y
ducción al castellano de la escala HoNOS. Psiquiatría Pública abuso de sustancias rastornos sustancias. Editorial Médica
1999; 11: 93-101. Panamericana SA. Madrid: 201-219.
49. Kessler, R.C., & Ustun, T.B. (2004). The World Mental Health
(WMH) Survey Initiative Version of the World Health 66. O’Hare T, Sherrer MV, LaButti A, Emrick K. Validating the
Organization (WHO) Composite International Diagnostic Alcohol Use Disorders Identification Test with Persons Who
Interview (CIDI). The Journal of Methods in Psychiatric Have a Serious Mental Illness. Research on Social Work
Research. Practice.2004; 14: 36-42
50. Hasin DS, Trautman KD, Miele GM, Samet S, Smith M,
Endicott J. Psychiatric Research Interview for Substance and 67. Rosenberg SD, Drake RE, Wolford GL, Mueser KT, Oxman TE,
Mental Disorders (PRISM): reliability for substance abusers. Am Vidaver RM, Carrieri KL, Luckoor R. 1998. Dartmouth
J Psychiatry 1996 Sep;153(9):1195-201. Assessment of Lifestyle Instrument (DALI): a substance use
51. Serrano D, Pérez G, Astals M, Martín-Santos R, Castillo C, Torrens disorder screen for people with severe mental illness. Am J
M. Validación de la versión española de la Psychiatric Research Psychiatry 1998 Feb;155(2):232-8
Interview for Substance and Mental Disorders (PRISM) VIII
Congreso Nacional de la Sociedad Española de Toxicomanias. 68. Ford P. An evaluation of the Dartmouth Assessment of Lifestyle
Trastronos Adictivos oct 2001 Vol 3 n.º 4 p 293-293. Inventory and the Leeds Dependence Questionnaire for use
52. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, among detained psychiatric inpatients. Addiction Volume 98,
Weiller E et al. The Mini-International Neuropsychiatric Number 1, 2003
Interview (MINI): the development and validation of a structu-
red diagnostic psychiatric interview for DSM-IV and ICD-10. J 69. Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W et al.
Clin Psychiatry 1998; 59: 22-23, 34-57. The Severity of Dependence Scale (SDS) psychometric properties
53. Ferrando L, Bobes J, Gibert J, Lecrubier Y. Mini International of the SDS in English and Australian samples of heroin, cocaine
Neuropsychiatric Interview. En: Bobes J, Bousoño M, González and amphetamines users. Addiction. 1995;90:607-14.
MP, editores. Manejo de los trastornos mentales y del comporta-
miento en Atención Primaria. 2.ª ed. Oviedo: Gofer; 1997. 70. De Las Cuevas C, Sanz EJ, De La Fuente JA, Padilla J, Berenguer
54. Martínez Delgado JM. Instrumentos para el diagnóstico precoz JC. The Severity of Dependence Scale (SDS) as screening test for
de los problemas derivados del consumo de bebidas alcohólicas. benzodiazepine dependence: SDS validation study. Addiction
Coloquios en Drogodependencias n.º 12. 2000 95:2 245.
55. Ewing JA. Detecting alcoholism: the CAGE questionnaire.
JAMA 1984; 252: 1905-7. 71. González Saiz, F.; Salvador Carulla, L.; «Estudio de fiabilidad y
56. Rodríguez-Martos A, Navarro RM, Vecino C, Pérez R. validez de la versión española de la escala Severity of Dependence
Validación de los cuestionarios KFA (CBA) y CAGE para el diag- Scale (SDS)» Adicciones : revista de socidrogalcohol 1998 ; 10(3)
nóstico del alcoholismo. Drogalcohol 1986; 11: 132-9 : 223-232
72. Bloye D, Ramzan A, Leach C, Davies L, Milton R. Substance use
disorders in patients admitted to a medium secure unit: a com-
parison of three assessment measures. Journal of Forensic
Psychiatry and Psychology. Vol 14, N.º 3; 2003: 585 – 599
73. Minkoff K (2000), Mental Illness and Drug and Alcohol
Screening (MIDAS). Unpublished manuscript. En Cynthia M. A.
Geppert, M.D., and Minkoff K. Issues in Dual Diagnosis:
Diagnosis, Treatment and New Research. © Psychiatric Times
April 2004 Vol. XXI XXXilla 4.
74. Raistrick D, Bradshaw J, Tober G, Weiner J, Allison J, Healey C:
Development of the Leeds Dependence Questionnaire (LDQ): a
questionnaire to measure alcohol and opiate dependence in the
context of a treatment evaluation package. Addiction 1994;
89:563–572
Evaluación en Rehabilitación Psicosocial 89
